
1. Moving the Markets
There was much hope of the Fed showing signs of not only relenting from their planned interest rate hikes in 2016 but possibly shifting in reverse and lowering rates in the very near future.
Such was the anticipation as Fed chief Yellen delivered testimony in front of a congressional committee, which also had the opportunity to participate in a Q&A session. While equities displayed some exuberance early on, the major indexes slid in the afternoon as it became clear that no assist to push stocks out of their doldrums was forthcoming.
Yellen said that financial conditions “have become less supportive to growth” and “downside risks” are largely stemming from uncertainty over the state of the Chinese economy. In the end, Yellen left the door wide open as to further rate increases in 2016. To me, that means that equities have to find another driver to push prices higher as the Fed, at least for the time being, is not showing an accommodative stance.
With the markets ending basically unchanged, only 3 of our 10 ETFs in the Spotlight made a dash above the unchanged line led by Healthcare (XLV) with +0.87%. On the downside, the Select Dividend ETF (DVY) lost -0.38%.



The US economy has been growing at 2 percent real and perhaps 2.9 percent nominal for the past several years, said Bill Gross, portfolio manager at Janus Capital Group.
Amid heightened market volatility and slumping Treasury yields, many investors have started to believe lower rates will linger for a bit longer, meaning dividend plays could make hay for an extended period while the Fed falters. Such a scenario may look ideal for a strategically timed new smart-beta product from Guggenheim Investments.